Current Anticoagulation Recommendation for COVID-19 Patients

Indra Prasetya


Thromboembolic events in COVID-19 patients can be one of the factors that aggravate the disease and increase mortality. When severe hypoxemia and hypotension occur in COVID-19 patients, the possibility of embolism should be considered. As a result, anticoagulant therapy in COVID-19 patients has an essential role in lowering disease severity and mortality. Many studies report that giving anticoagulants to COVID-19 patients can reduce mortality. Therefore, it is important to understand the role and use of anticoagulant therapy in cases of COVID-19. Several guidelines that have been issued by several health organizations in the world and Indonesia can be used as guidelines for clinicians to start anticoagulant therapy in cases of COVID-19. Various anticoagulant drug regimens have also been recommended to be used both as prophylaxis and as therapy for thromboembolism that can occur after COVID-19 cases.


Thromboembolic Events; Anticoagulants; COVID-19; Guidelines.

Full Text:



Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thrombo- embolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 2020;4(7):1178–91. 10.1002/rth2.12439

Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hema- tology 2021 guidelines on the use of anticoagulation for thrombo- prophylaxis in patients with COVID-19. Blood Adv 2021;5(3):872–88. 10.1182/bloodadvances.2020003763

Burhan E, Susanto AD, Nasution SA, et al. Protokol Tatalaksana Covid-19. 4th ed. Jakarta: 2021.

AlHajri L, Gebran N. The Use of Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Medical Patients: How Much Are We Adherent to the Guidelines? Open J Intern Med 2015;05(04):81–91. 10.4236/ojim.2015.54012

European Society of cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Eur Heart J 2020;1–115.

Atallah B, Mallah SI, AlMahmeed W. Anticoagulation in COVID-19. Eur Hear J - Cardiovasc Pharmacother 2020;6(4):260–1. https://- 10.1093/ehjcvp/pvaa036

COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Disponible en: https://- Natl Inst Heal 2020;2019:130. https://www.covid19treatmentguide-



  • There are currently no refbacks.

Copyright (c) 2021 Indra Prasetya

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.